Resource Library
Expediting biologics drug development downstream strategies to accelerate preclinical development timelines
To streamline the path to commercialization, partnering with a CDMO with in silico analyses and process development proficiency is crucial. In this whitepaper, Songyoung Kim, Principal Scientist in Downstream Process Development, discusses how our accumulated experience in downstream enables rapid and reliable product development tailored to meet each project’s needs.
To streamline the path to commercialization, partnering with a CDMO with in silico analyses and process development proficiency is crucial. In this whitepaper, Songyoung Kim, Principal Scientist in Downstream Process Development, discusses how our accumulated experience in downstream enables rapid and reliable product development tailored to meet each project’s needs.